22.5 C
New York
Wednesday, June 17, 2026

Tag: business development

newssourceFORcompanyinformationcontent1marketreleases

FS Bancorp, Inc. Announces CEO Succession Plan

Retiring Chief Executive Officer Joe Adams Remains CEO of FS Bancorp until May 2026; Matt Mullet Named President and CEO of 1st Security Bank and will continue as President of FS Bancorp.

Tuniu Announces Unaudited Second Quarter 2025 Financial Results

NANJING, China, Aug. 15, 2025 /PRNewswire/ -- Tuniu Corporation (NASDAQ: TOUR) ("Tuniu" or the "Company"), a leading online leisure travel company in China, today announced...

So-Young Reports Unaudited Second Quarter 2025 Financial Results

BEIJING, Aug. 15, 2025 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers...

XPENG and the Volkswagen Group Announce Entry into Agreement on Expanding E/E Architecture Technical Collaboration

XPENG and the Volkswagen Group Announce Entry into Agreement on Expanding E/E Architecture Technical Collaboration

COSCIENS Biopharma Inc. Reports Second Quarter 2025 Financial Results and Provides Strategic Initiatives Update

COSCIENS Board of Directors approves a plan to voluntarily delist from Nasdaq, while retaining the Company’s listing on the TSX

Hesai Group Reports Second Quarter 2025 Unaudited Financial Results

Quarterly net revenues were RMB706.4 million (US$98.6 million)1
Quarterly lidar shipments were 352,095 units
Quarterly net income was RMB44.1 million (US$6.2 million)

Chicago Atlantic BDC, Inc. Declares $0.34 Cash Dividend for Third Quarter 2025

NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Chicago Atlantic BDC, Inc. (“the “Company”) (NASDAQ: LIEN), a specialty finance company that has elected to be regulated as a business development company, today announced that the Company’s board of directors has declared a cash dividend of $0.34 per share for the quarter ending September 30, 2025.

Shattuck Labs Reports Second Quarter 2025 Financial Results and Recent Business Highlights

– Submitted Investigational New Drug (IND) application to evaluate SL-325 in a Phase 1 clinical trial in healthy volunteers; clearance expected in Q3 2025 –

Golar LNG Limited Interim results for the period ended June 30, 2025

Highlights and subsequent events

Minesto publishes Half-Year Report 2025

GOTHENBURG, Sweden, Aug. 14, 2025 /PRNewswire/ -- CEO Dr Martin Edlund: "As the leading pioneer in Ocean Renewable Energy, Minesto moves on with more determination and...

Minesto publishes Half-Year Report 2025

GOTHENBURG, Sweden, Aug. 14, 2025 /PRNewswire/ -- CEO Dr Martin Edlund: "As the leading pioneer in Ocean Renewable Energy, Minesto moves on with more determination and...

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY® by the Taiwan Food and Drug Administration for the Treatment of Moderately to...

SHANGHAI, Aug. 14, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing...

Entrepreneur Universe Bright Group Reports Second Quarter 2025 Financial Results

XI'AN, China, Aug. 14, 2025 /PRNewswire/ -- Entrepreneur Universe Bright Group ("EUBG" or the "Company"), a Nevada corporation, today announced its unaudited financial results for...

Seguritech to Attend Mexico’s Industry Supply Chain Expo August 13-14

Joining Other Leading Companies to Explore the Entire Industry Value Chain in Mexico MIAMI, Aug. 13, 2025 /PRNewswire/ -- Seguritech, a leader in advanced security...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsBusiness development

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers